Health Care/Hospital APAC News & Press Release Distribution

Health Care/Hospital

All
Global

Heranova to Unveil HerResolve™, a Revolutionary Non-Invasive Endometriosis Test, at the Ovarian Club Asian Conference in Hong Kong

92% Diagnostic Accuracy with a Simple Blood Test for Early Diagnosis and Treatment of Endometriosis HONG KONG, Dec. 13, 2024 /PRNewswire/ -- Heranova, a leader in women's health innovation, is excited to announce the launch of HerResolve™, a groundbreaking non-invasive test for endometriosis, at...

2024-12-13 08:00 2222

2024 SABCS｜Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis

YANTAI, China, Dec. 13, 2024 /PRNewswire/ -- On the morning of December 12, 2024 (UTC-6), at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS),RemeGen Co. Ltd. ("RemeGen") (9995.HK, 688331.SH) presented for the first time the data from ...

2024-12-13 07:20 761

DID YOU HAVE A HIP, KNEE, OR OTHER JOINT REPLACEMENT?

If your implant/replacement involved Exactech products – including Optetrak, Optetrak Logic, Truliant, Vantage, Connexion GXL, and Equinoxe – your attention to this notice is important. NEW YORK, Dec. 12, 2024 /PRNewswire/ -- The following is being issued by Kroll Restructuring Administration L...

2024-12-12 23:19 1414

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

- A Milestone in Preventive Healthcare and Technological Innovation in Long An TÂN AN CITY, Vietnam, Dec. 12, 2024 /PRNewswire/ -- Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to developVietnam's first AI x ESG Hospital, marking a significant milestone...

2024-12-12 21:23 1983

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

Xinhua Silk Road: Pien Tze Huang boosts TCM globalization

BEIJING, Dec. 12, 2024 /PRNewswire/ -- Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd., aFujian-based traditional Chinese medicine (TCM) company, has been striving to expand its overseas markets, enhancing the influence of TCM in regions such asSoutheast Asia and Europe. Committed to deepening...

2024-12-12 20:43 1815

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

* ADELA, an international phase III study being conducted across multiple countries, combines elacestrant with everolimus to treat advanced ER+/HER2- breast cancer withESR1 mutations, aiming to delay disease progression. * The study was presented by the Menarini Group and MEDSIR at the San Ant...

2024-12-12 18:07 1571

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

New collaboration delivers cashless services, as well as access to expedited appointments for outpatient cancer treatment services and independent cancer medical consultation, ensuring comprehensive and convenient protection for customers HONG KONG, Dec. 12, 2024 /PRNewswire/ -- Manulife Hong Ko...

2024-12-12 17:30 1930

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

Waterdrop Inc. Announces Third Quarter 2024 Unaudited Financial Results, Net profit rises 152.6% year-on-year

BEIJING, Dec. 12, 2024 /PRNewswire/ -- On December 11, 2024, Waterdrop Inc. (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare services with a positive social impact, unveiled its unaudited financial results for the third quarter of 2024 endedSeptember 30, 2024. Duri...

2024-12-12 16:13 2187

CBC Group R-Bridge Healthcare Fund Announces up to US$50 Million Financing for Human Investments Ltd. to Fund Motiva® Market Expansion

* Non-dilutive growth financing of up to US$50 million, with a synthetic royalty feature, and availability linked to achievement of certain sales milestones * Proceeds from the financing will fund Human Investments Ltd.'s expansion of Motiva® devices inAsia * Transaction highlights R-Bridge...

2024-12-12 14:14 3044

Everest Medicines Announces the First Prescription of VELSIPITY® Issued in Macau, Officially Beginning to Benefit Asian Patients

SHANGHAI, Dec. 12, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that the first prescription of VELSIP...

2024-12-12 11:48 1810

QNET Stands in Solidarity with Cambodia and the World for a Mine-Free Future

HONG KONG, Dec. 12, 2024 /PRNewswire/ -- QNET, a global leader in direct selling and lifestyle products, proudly sponsored the recently concluded'March for aMine-Free World' in Siem Reap, Cambodia. This impactful event, hosted in collaboration with the Cambodian Mine Action and Victim Assistance ...

2024-12-12 01:34 2850

QNET Stands in Solidarity with Cambodia and the World for a Mine-Free Future

THERME GROUP ACQUIRES THERME ERDING AND SECURES €320 MILLION FINANCING, TO CREATE THE WORLD'S LARGEST WELLBEING INFRASTRUCTURE PLATFORM

The Acquisition of Europe's Largest Wellbeing Destination, Backed by One of the Industry's Largest Single-Asset Financings LONDON, Dec. 12, 2024 /PRNewswire/ -- Therme Group announces the acquisition ofTherme Erding, the largest wellbeing destination globally located near Munich inGermany. With ...

2024-12-12 00:03 2742

GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz™

** IND submitted to the FDA showing significantly improved patient condition when administered within 70 minutes of arrival at the Emergency Room ** *Multinational Phase 3 Clinical Trial protocols confirmed and initiated with leading global stroke research centers * SEOUL, South Korea, Dec. 11, ...

2024-12-11 23:15 1944

Viva Biotech Officially Establishes Boston Branch, Marking Another Milestone in Global Expansion

HONG KONG, Dec. 11, 2024 /PRNewswire/ -- Recently, Viva Biotech Holdings Group ("Viva Biotech") announced the official establishment of its new branch inBoston ,USA. As a global leader in drug research, development and manufacturing services, this milestone marks a significant step forward in the ...

2024-12-11 14:44 2243

Call for Application for 2025 Tsinghua Amgen Scholars Program

BEIJING, Dec. 11, 2024 /PRNewswire/ -- The Amgen Scholars Program (ASP) is an international program funded by the Amgen Foundation with the direction of Harvard University, aiming to increase research opportunities for students committed to pursuing careers in the field of biomedical science. Thro...

2024-12-11 14:33 2308

Call for Application for 2025 Tsinghua Amgen Scholars Program

2024 PHBS-CJBS Global Pitch Competition Grand Final Held

SHENZHEN, China, Dec. 11, 2024 /PRNewswire/ -- The 2024 PHBS-CJBS Global Pitch Competition, jointly hosted by Peking University HSBC Business School (PHBS) and Cambridge Judge Business School (CJBS), concluded with its grand final on December 5th at PHBS in Shenzhen, China. During the finals...

2024-12-11 12:29 1359

2024 PHBS-CJBS Global Pitch Competition Grand Final Held

AXA and HKBN Deepen Collaboration with Launch of "HKBN SmartTraveller Plus"

Providing comprehensive travel protection for worry-free travelling HONG KONG, Dec. 11, 2024 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") and Hong Kong Broadband Network Limited ("HKBN") have taken their collaboration another step forward by introducing"HKBN SmartTraveller Plus", a travel ins...

2024-12-11 11:52 2125

AXA and HKBN Deepen Collaboration with Launch of

Community Med Care's " Uplift with Love - Angel Mission" 6th Anniversary

Invitation to All to Send a Christmas Gift of Hope to Sick Children HONG KONG, Dec. 11, 2024 /PRNewswire/ -- Traditionally, Santa Claus has a Nice List and a Naughty List for giving gifts to children. This year, Community Med Care encourages you to become a caring Santa by creating a "Beneficiar...

2024-12-11 09:00 1544

Partnership Established to Advance WHO's Road Map for Neglected Tropical Diseases 2021-2030

TOKYO and GENEVA, Dec. 11, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund and the World Health Organization (WHO) have signed a memorandum of understanding (MoU) to further expand their partnership to promote access to safe, effective and affordable drugs, vaccines and ...

2024-12-11 09:00 1255

Live from ASH 2024 | Oral Report Features Encouraging Data of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in R/R MM, Including a Median PFS Over 9 Months

ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has released t...

2024-12-10 22:31 2118

1 2 3 456 7 8 ... 575